FLT4 Antikörper (C-Term)
Kurzübersicht für FLT4 Antikörper (C-Term) (ABIN1839820)
Target
Alle FLT4 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- C-Term
-
Aufreinigung
- Immunoaffinity purified
-
Immunogen
-
A synthetic peptide derived from C-terminus of human Flt-4.
Type of Immunogen: Synthetic peptide
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Kommentare
-
Target Species of Antibody: Human
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- Lot specific
-
Buffer
- 10 mM PBS, pH 7.4, BSA, sodium azide.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handhabung
- Do not freeze.
-
Lagerung
- 4 °C
-
Informationen zur Lagerung
- Store at 2-8°C. Do not freeze.
-
-
- FLT4 (Fms-Related Tyrosine Kinase 4 (FLT4))
-
Andere Bezeichnung
- FLT4 / VEGFR3
-
Hintergrund
-
Name/Gene ID: FLT4
Subfamily: VEGF Receptor
Family: Protein Kinase
Synonyms: FLT4, FLT41, Fms-related tyrosine kinase 4, Fms-like tyrosine kinase 4, LMPH1A, PCL, Soluble VEGFR3 variant 1, Vegf-r3, VEGFR3, Soluble VEGFR3 variant 2, Soluble VEGFR3 variant 3, FLT-4, Quek2, VEGF Receptor 3, VEGFR-3 -
Gen-ID
- 2324
-
Pathways
- RTK Signalweg, Signaling Events mediated by VEGFR1 and VEGFR2, VEGF Signaling
Target
-